Tirellizumab Plus Concurrent Chemoradiation in Older With ESCC

Conditions: Esophageal Cancer Interventions: Drug: Arm A; Drug: Arm A; Radiation: Arm A; Drug: Arm B; Radiation: Arm B Sponsors: Tianjin Medical University Cancer Institute and Hospital; Sichuan Cancer Hospital and Research Institute; Shanxi Province Cancer Hospital; Henan Cancer Hospital; Hunan Cancer Hospital; The First Affiliated Hospital with Nanjing Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials